07:00 , Aug 8, 2005 |  BC Week In Review  |  Company News

Aptanomics SA, Boehringer Ingelheim deal

Aptanomics will provide Boehringer with a panel of peptide aptamers for validating BI's targets and identifying druggable sites. Financial terms were not disclosed. Aptanomics SA , Lyon, France   Boehringer Ingelheim GmbH , Ingelheim, Germany...
07:00 , May 10, 2004 |  BC Week In Review  |  Company News

Aptanomics SA, Nanosyn Inc. deal

Aptanomics will use its peptide aptamer technology to screen small organic compound libraries from Nanosyn to discover potential cancer therapies. Nanosyn will use its Chemistry on Demand screening technology on identified hits to provide Aptanomics...
07:00 , Jun 30, 2003 |  BC Week In Review  |  Company News

Aptanomics SA management update

Aptanomics SA , Lyon, France   Business: Proteomics, Chemistry   Hired: Michael Courtney as chairman and CEO, formerly COO of Noxxon Pharma AG ; he replaces John Hawken  ...
07:00 , Jun 24, 2003 |  BC Extra  |  Company News

Aptanomics hires Courtney as CEO

Aptanomics (Lyon,France), which is developing small molecule therapeutics using its peptide aptamer technology, hired Michael Courtney as chairman and CEO. Courtney was most recently COO of Noxxon (Berlin, Germany). He replaces acting CEO John Hawken,...